Prosecution Insights
Last updated: October 25, 2026

I Peace Inc.

Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems

5 pending office actions • 3 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

I Peace Inc. has 5 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 4 distinct examiners and 3 distinct art units, indicating some concentration of the docket within the technical examination structure.

JOS, BASIL T is the busiest listed examiner, with 2 pending matters. Counsel should coordinate positions across the portfolio while accounting for the examiner-specific handling of that concentrated portion of the docket.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

5
Total Pending OAs
4
Non-Final OAs
0
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (60%)
2
Medium (40%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (20%)
§102 only2 (40%)
Multi-statute (no §101)2 (40%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
60% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
40% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
JOS, BASIL T 2 78.0% +6.3%
CORDAS, EMILY ANN 1 50.9% +57.4%
RIGA, MICHAEL ANGELO 1 56.2% +63.0%
EBBINGHAUS, BRIANA NOEL 1 59.7% +63.0%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18146897 METHOD FOR PRODUCING NERVE CELL, METHOD FOR PRODUCING MOTOR NEURON, AND METHOD FOR SCREENING NEUROLOGICAL DISEASE THERAPEUTIC DRUG EBBINGHAUS, BRIANA NOEL 100d overdue
18919995 PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION CORDAS, EMILY ANN —
18615184 METHOD FOR SCREENING SUBSTANCE, SYSTEM FOR SCREENING SUBSTANCE, METHOD FOR PRODUCING A CLUMP FROM STEM CELLS, AND METHOD FOR PRODUCING DIFFERENTIATED CELLS RIGA, MICHAEL ANGELO —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18146897 METHOD FOR PRODUCING NERVE CELL, METHOD FOR PRODUCING MOTOR NEURON, AND METHOD FOR SCREENING NEUROLOGICAL DISEASE THERAPEUTIC DRUG EBBINGHAUS, BRIANA NOEL 100d overdue
18919995 PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION CORDAS, EMILY ANN —
18615184 METHOD FOR SCREENING SUBSTANCE, SYSTEM FOR SCREENING SUBSTANCE, METHOD FOR PRODUCING A CLUMP FROM STEM CELLS, AND METHOD FOR PRODUCING DIFFERENTIATED CELLS RIGA, MICHAEL ANGELO —

Top Art Units

Art UnitApps
3656 2
1632 2
1653 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19251801 CELL PRODUCTION SYSTEM JOS, BASIL T 3656 §102 Non-Final OA — Pending Jun 27, 2025
19251802 CELL PRODUCTION SYSTEM JOS, BASIL T 3656 §102 Non-Final OA — Pending Jun 27, 2025
18919995 PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION CORDAS, EMILY ANN 1632 §102§103 Non-Final OA — Pending Oct 18, 2024
18615184 METHOD FOR SCREENING SUBSTANCE, SYSTEM FOR SCREENING SUBSTANCE, METHOD FOR PRODUCING A CLUMP FROM STEM CELLS, AND METHOD FOR PRODUCING DIFFERENTIATED CELLS RIGA, MICHAEL ANGELO 1653 §101§102§112 Non-Final OA — Pending Mar 25, 2024
18146897 METHOD FOR PRODUCING NERVE CELL, METHOD FOR PRODUCING MOTOR NEURON, AND METHOD FOR SCREENING NEUROLOGICAL DISEASE THERAPEUTIC DRUG EBBINGHAUS, BRIANA NOEL 1632 §103§112 Non-Final OA 100d overdue Pending Dec 27, 2022

Managing I Peace Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does I Peace Inc. have?

I Peace Inc. has 5 pending office actions as of October 2026, spread across 3 art units and 4 examiners.

Which USPTO examiner handles the most I Peace Inc. applications?

Basil T Jos has the most, with 2 of I Peace Inc.'s pending office actions.

What technology area are I Peace Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month